| Neuroinflammation, stem cells, and stroke S Anthony, D Cabantan, M Monsour, CV Borlongan Stroke 53 (5), 1460-1472, 2022 | 42 | 2022 |
| A review of the pathology and treatment of TBI and PTSD M Monsour, D Ebedes, CV Borlongan Experimental neurology 351, 114009, 2022 | 38 | 2022 |
| Assessment of brain age in posttraumatic stress disorder: Findings from the ENIGMA PTSD and brain age working groups AN Clausen, KA Fercho, M Monsour, S Disner, L Salminen, CC Haswell, ... Brain and behavior 12 (1), e2413, 2022 | 32 | 2022 |
| The central role of peripheral inflammation in ischemic stroke M Monsour, CV Borlongan Journal of Cerebral Blood Flow & Metabolism 43 (5), 622-641, 2023 | 15 | 2023 |
| The role of IL-6 in TBI and PTSD, a potential therapeutic target? M Monsour, DM Croci, S Agazzi Clinical neurology and neurosurgery 218, 107280, 2022 | 12 | 2022 |
| Metabolic switching of cultured mesenchymal stem cells creates super mitochondria in rescuing ischemic neurons A Gorsky, M Monsour, H Nguyen, V Castelli, JY Lee, CV Borlongan NeuroMolecular Medicine 25 (1), 120-124, 2023 | 9 | 2023 |
| Cerebral aneurysm and interleukin-6: a key player in aneurysm generation and rupture or just one of the multiple factors? M Monsour, DM Croci, BE Grüter, P Taussky, S Marbacher, S Agazzi Translational Stroke Research 14 (5), 631-639, 2023 | 7 | 2023 |
| Contemplating IL‐6, a double‐edged sword cytokine: Which side to use for stroke pathology? M Monsour, DM Croci, S Agazzi, CV Borlongan CNS Neuroscience & Therapeutics 29 (2), 493-497, 2023 | 7 | 2023 |
| Probing interleukin-6 in stroke pathology and neural stem cell transplantation GM Lockard, A Alayli, M Monsour, J Gordon, S Schimmel, B Elsayed, ... International Journal of Molecular Sciences 23 (24), 15453, 2022 | 7 | 2022 |
| Patching up the permeability: the role of stem cells in lessening neurovascular damage in amyotrophic lateral sclerosis M Monsour, S Garbuzova-Davis, CV Borlongan Stem Cells Translational Medicine 11 (12), 1196-1209, 2022 | 7 | 2022 |
| Microclots in subarachnoid hemorrhage: an underestimated factor in delayed cerebral ischemia? M Monsour, DM Croci, S Agazzi Clinical Neurology and Neurosurgery 219, 107330, 2022 | 7 | 2022 |
| Mitochondria in cell-based therapy for stroke M Monsour, J Gordon, G Lockard, A Alayli, CV Borlongan Antioxidants 12 (1), 178, 2023 | 6 | 2023 |
| The role of concomitant Nrf2 targeting and stem cell therapy in cerebrovascular disease J Gordon, G Lockard, M Monsour, A Alayli, CV Borlongan Antioxidants 11 (8), 1447, 2022 | 6 | 2022 |
| The impact of climate change on the prevalence of mental illness symptoms M Monsour, E Clarke-Rubright, W Lieberman-Cribbin, C Timmins, E Taioli, ... Journal of Affective Disorders 300, 430-440, 2022 | 6 | 2022 |
| Getting the guts to expand stroke treatment: the potential for microbiome targeted therapies M Monsour, DM Croci, S Agazzi, CV Borlongan CNS Neuroscience & Therapeutics 29, 213-219, 2023 | 5 | 2023 |
| Enhancing oxidative phosphorylation over glycolysis for energy production in cultured mesenchymal stem cells M Monsour, A Gorsky, H Nguyen, V Castelli, JY Lee, CV Borlongan Neuroreport 33 (15), 635-640, 2022 | 4 | 2022 |
| An understated comorbidity: the impact of homelessness on traumatic brain injury M Monsour, JY Lee, CV Borlongan Neurotherapeutics 20 (6), 1446-1456, 2023 | 3 | 2023 |
| Sequestration of inflammation in Parkinson’s disease via stem cell therapy J Gordon, G Lockard, M Monsour, A Alayli, H Choudhary, CV Borlongan International Journal of Molecular Sciences 23 (17), 10138, 2022 | 3 | 2022 |
| Neurovascular unit permeability in neuroinflammatory diseases: a common pathologic and therapeutic target? M Monsour, CV Borlongan Neural Regeneration Research 18 (8), 1715-1716, 2023 | 2 | 2023 |
| Stem cells: recent developments redefining epilepsy therapy A Alayli, G Lockard, J Gordon, J Connolly, M Monsour, S Schimmel, ... Cell Transplantation 32, 09636897231158967, 2023 | 2 | 2023 |
